© Reuters. FILE PHOTO: Undated handout image of Vectura’s AKITA JET inhalation system provided to Reuters July 9, 2021. Vectura/Handout via REUTERS
(Reuters) -Philip Morris has raised its bid for British drugmaker Vectura to 165 pence ($2.29) per share, the tobacco company said on Sunday.
“The PMI (Philip Morris (NYSE:) International) increased offer values the entire issued and to be issued ordinary share capital of Vectura at approximately 1.02 billion pounds ($1.41 billion),” it said in an emailed statement to Reuters.
The latest offer represents a premium of approximately
10 pence per share to a rival offer of 155 pence a share by U.S.-based Carlyle Group (NASDAQ:) announced on Friday.
Carlyle offered to buy Vectura for about 958 million pounds ($1.3 billion).
Vectura, which makes respiratory treatments, had said on Friday that it was backing Carlyle’s offer and withdrawing its recommendation for Philip Morris’ proposal, adding that it might be better positioned under Carlyle’s ownership.
Vectura did not immediately respond to a Reuters request for comment.
($1 = 0.7209 pounds)
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
